Patent ID: 9733259
Date: 2017-08-15
CPC Classifications: A61P,C12Q,G01N

Claim:
1. A method of assessing a subject for abnormal kidney function, which is defined as an albumin creatinine ratio (ACR) of 3.5 or more, comprising measuring the concentration of at least one biomarker in a sample from the subject, wherein said at least one biomarker is CD5 antigen like, and based on the measured concentration: (i) designating the subject as having abnormal kidney function where the measured concentration is consistent with concentrations of the at least one biomarker in samples from subjects who have abnormal kidney function; (ii) designating the subject as having an increased risk of developing abnormal kidney function where the measured concentration is consistent with concentrations of the at least one biomarker in samples from subjects who have an increased risk of developing abnormal kidney function; or (iii) designating the subject as not having abnormal kidney function or an increased risk of developing abnormal kidney function where the measured concentration is consistent with concentrations of the at least one biomarker in samples from subjects who do not have abnormal kidney function or an increased risk of developing abnormal kidney function.